NCT05426486 2024-10-30A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer PatientsShengjing HospitalPhase 2/3 Active not recruiting136 enrolled